Relmada Therapeutics

+$0.43 (+1.59%) As of 2:32 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.

About RLMD

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. It focuses on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist, which is a New Chemical Entity (NCE) that potentially addresses areas of high unmet medical need in the treatment of central nervous system (CNS) diseases and other disorders.

CEO
Sergio Traversa
Employees
14
Headquarters
New York, New York
Founded
2012

RLMD Key Statistics

Market Cap
481.21M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
129.71K
High Today
$27.77
Low Today
$27.18
Open Price
$27.18
Volume
31.41K
52 Week High
$40.47
52 Week Low
$20.60

RLMD Earnings

-$1.56
-$1.04
-$0.52
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure